United States Acute Ischemic Stroke Diagnosis and Treatment Market Report 2016

November 2016 | 117 pages | ID: UC1CBABFD43EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Acute Ischemic Stroke Diagnosis and Treatment

Revenue, means the sales value of Acute Ischemic Stroke Diagnosis and Treatment

This report studies sales (consumption) of Acute Ischemic Stroke Diagnosis and Treatment in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Hitachi
• GE Healthcare
• Johnson & Johnson
• Stryker Corporatio
• Penumbra
• Philips Healthcare
• Siemens Healthcare
• Abbott Laboratories
• Covidien

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• CT
• MRI
• Ultrasound
• Cerebral angiography
• Others

Split by applications, this report focuses on sales, market share and growth rate of Acute Ischemic Stroke Diagnosis and Treatment in each application, can be divided into

• Carotid endarterectomy
• Angioplasty
• Endovascular mechanical thrombectony
• Others

Contents

United States Acute Ischemic Stroke Diagnosis and Treatment Market Report 2016

1 ACUTE ISCHEMIC STROKE DIAGNOSIS AND TREATMENT OVERVIEW

1.1 Product Overview and Scope of Acute Ischemic Stroke Diagnosis and Treatment
1.2 Classification of Acute Ischemic Stroke Diagnosis and Treatment
  1.2.1 CT
  1.2.2 MRI
  1.2.3 Ultrasound
  1.2.4 Cerebral angiography
  1.2.5 Others
1.3 Application of Acute Ischemic Stroke Diagnosis and Treatment
  1.3.1 Carotid endarterectomy
  1.3.2 Angioplasty
  1.3.3 Endovascular mechanical thrombectony
  1.3.4 Others
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Acute Ischemic Stroke Diagnosis and Treatment (2011-2021)
  1.4.1 United States Acute Ischemic Stroke Diagnosis and Treatment Sales and Growth Rate (2011-2021)
  1.4.2 United States Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2011-2021)

2 UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS AND TREATMENT COMPETITION BY MANUFACTURERS

2.1 United States Acute Ischemic Stroke Diagnosis and Treatment Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Acute Ischemic Stroke Diagnosis and Treatment Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Acute Ischemic Stroke Diagnosis and Treatment Average Price by Manufactures (2015 and 2016)
2.4 Acute Ischemic Stroke Diagnosis and Treatment Market Competitive Situation and Trends
  2.4.1 Acute Ischemic Stroke Diagnosis and Treatment Market Concentration Rate
  2.4.2 Acute Ischemic Stroke Diagnosis and Treatment Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS AND TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Acute Ischemic Stroke Diagnosis and Treatment Sales and Market Share by Type (2011-2016)
3.2 United States Acute Ischemic Stroke Diagnosis and Treatment Revenue and Market Share by Type (2011-2016)
3.3 United States Acute Ischemic Stroke Diagnosis and Treatment Price by Type (2011-2016)
3.4 United States Acute Ischemic Stroke Diagnosis and Treatment Sales Growth Rate by Type (2011-2016)

4 UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS AND TREATMENT SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Acute Ischemic Stroke Diagnosis and Treatment Sales and Market Share by Application (2011-2016)
4.2 United States Acute Ischemic Stroke Diagnosis and Treatment Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS AND TREATMENT MANUFACTURERS PROFILES/ANALYSIS

5.1 Hitachi
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Acute Ischemic Stroke Diagnosis and Treatment Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Hitachi Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 GE Healthcare
  5.2.2 Acute Ischemic Stroke Diagnosis and Treatment Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 GE Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Johnson & Johnson
  5.3.2 Acute Ischemic Stroke Diagnosis and Treatment Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Johnson & Johnson Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Stryker Corporatio
  5.4.2 Acute Ischemic Stroke Diagnosis and Treatment Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Stryker Corporatio Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Penumbra
  5.5.2 Acute Ischemic Stroke Diagnosis and Treatment Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Penumbra Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Philips Healthcare
  5.6.2 Acute Ischemic Stroke Diagnosis and Treatment Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Philips Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Siemens Healthcare
  5.7.2 Acute Ischemic Stroke Diagnosis and Treatment Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Siemens Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Abbott Laboratories
  5.8.2 Acute Ischemic Stroke Diagnosis and Treatment Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Abbott Laboratories Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Covidien
  5.9.2 Acute Ischemic Stroke Diagnosis and Treatment Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Covidien Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview

6 ACUTE ISCHEMIC STROKE DIAGNOSIS AND TREATMENT MANUFACTURING COST ANALYSIS

6.1 Acute Ischemic Stroke Diagnosis and Treatment Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Acute Ischemic Stroke Diagnosis and Treatment

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Acute Ischemic Stroke Diagnosis and Treatment Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Acute Ischemic Stroke Diagnosis and Treatment Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS AND TREATMENT MARKET FORECAST (2016-2021)

10.1 United States Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue Forecast (2016-2021)
10.2 United States Acute Ischemic Stroke Diagnosis and Treatment Sales Forecast by Type (2016-2021)
10.3 United States Acute Ischemic Stroke Diagnosis and Treatment Sales Forecast by Application (2016-2021)
10.4 Acute Ischemic Stroke Diagnosis and Treatment Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Acute Ischemic Stroke Diagnosis and Treatment
Table Classification of Acute Ischemic Stroke Diagnosis and Treatment
Figure United States Sales Market Share of Acute Ischemic Stroke Diagnosis and Treatment by Type in 2015
Figure CT Picture
Figure MRI Picture
Figure Ultrasound Picture
Figure Cerebral angiography Picture
Figure Others Picture
Table Application of Acute Ischemic Stroke Diagnosis and Treatment
Figure United States Sales Market Share of Acute Ischemic Stroke Diagnosis and Treatment by Application in 2015
Figure Carotid endarterectomy Examples
Figure Angioplasty Examples
Figure Endovascular mechanical thrombectony Examples
Figure Others Examples
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Sales and Growth Rate (2011-2021)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate (2011-2021)
Table United States Acute Ischemic Stroke Diagnosis and Treatment Sales of Key Manufacturers (2015 and 2016)
Table United States Acute Ischemic Stroke Diagnosis and Treatment Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Acute Ischemic Stroke Diagnosis and Treatment Sales Share by Manufacturers
Figure 2016 Acute Ischemic Stroke Diagnosis and Treatment Sales Share by Manufacturers
Table United States Acute Ischemic Stroke Diagnosis and Treatment Revenue by Manufacturers (2015 and 2016)
Table United States Acute Ischemic Stroke Diagnosis and Treatment Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Acute Ischemic Stroke Diagnosis and Treatment Revenue Share by Manufacturers
Table 2016 United States Acute Ischemic Stroke Diagnosis and Treatment Revenue Share by Manufacturers
Table United States Market Acute Ischemic Stroke Diagnosis and Treatment Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Acute Ischemic Stroke Diagnosis and Treatment Average Price of Key Manufacturers in 2015
Figure Acute Ischemic Stroke Diagnosis and Treatment Market Share of Top 3 Manufacturers
Figure Acute Ischemic Stroke Diagnosis and Treatment Market Share of Top 5 Manufacturers
Table United States Acute Ischemic Stroke Diagnosis and Treatment Sales by Type (2011-2016)
Table United States Acute Ischemic Stroke Diagnosis and Treatment Sales Share by Type (2011-2016)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share by Type in 2015
Table United States Acute Ischemic Stroke Diagnosis and Treatment Revenue and Market Share by Type (2011-2016)
Table United States Acute Ischemic Stroke Diagnosis and Treatment Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Acute Ischemic Stroke Diagnosis and Treatment by Type (2011-2016)
Table United States Acute Ischemic Stroke Diagnosis and Treatment Price by Type (2011-2016)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Sales Growth Rate by Type (2011-2016)
Table United States Acute Ischemic Stroke Diagnosis and Treatment Sales by Application (2011-2016)
Table United States Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share by Application (2011-2016)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share by Application in 2015
Table United States Acute Ischemic Stroke Diagnosis and Treatment Sales Growth Rate by Application (2011-2016)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Sales Growth Rate by Application (2011-2016)
Table Hitachi Basic Information List
Table Hitachi Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Hitachi Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share (2011-2016)
Table GE Healthcare Basic Information List
Table GE Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table GE Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share (2011-2016)
Table Stryker Corporatio Basic Information List
Table Stryker Corporatio Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table Stryker Corporatio Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share (2011-2016)
Table Penumbra Basic Information List
Table Penumbra Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table Penumbra Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share (2011-2016)
Table Philips Healthcare Basic Information List
Table Philips Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table Philips Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share (2011-2016)
Table Siemens Healthcare Basic Information List
Table Siemens Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table Siemens Healthcare Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share (2011-2016)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share (2011-2016)
Table Covidien Basic Information List
Table Covidien Acute Ischemic Stroke Diagnosis and Treatment Sales, Revenue, Price and Gross Margin (2011-2016)
Table Covidien Acute Ischemic Stroke Diagnosis and Treatment Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Acute Ischemic Stroke Diagnosis and Treatment
Figure Manufacturing Process Analysis of Acute Ischemic Stroke Diagnosis and Treatment
Figure Acute Ischemic Stroke Diagnosis and Treatment Industrial Chain Analysis
Table Raw Materials Sources of Acute Ischemic Stroke Diagnosis and Treatment Major Manufacturers in 2015
Table Major Buyers of Acute Ischemic Stroke Diagnosis and Treatment
Table Distributors/Traders List
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Production and Growth Rate Forecast (2016-2021)
Figure United States Acute Ischemic Stroke Diagnosis and Treatment Revenue and Growth Rate Forecast (2016-2021)
Table United States Acute Ischemic Stroke Diagnosis and Treatment Production Forecast by Type (2016-2021)
Table United States Acute Ischemic Stroke Diagnosis and Treatment Consumption Forecast by Application (2016-2021)